Study finds no evidence linking reflux medicines to bone fractures

10 Oct 2017


A new study in Alimentary Pharmacology & Therapeutics reports that proton pump inhibitors (PPIs) are not linked to an increased risk of bone fractures or bone thinning, as it was previously believed.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story